CYP1A2*1F Gene Variant, Alkaline Salt Tea Intake and Risk of Esophageal Squamous Cell Carcinoma

References

• Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al.: The global burden of cancer 2013. JAMA Oncol 1, 505–527, 2015.
   PubMed Web of Science ®Google Scholar
• Rustgi AK, and El-Serag HB: Esophageal carcinoma. N Engl J Med 371, 2499–509, 2014.
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Ward EM, and Jemal A: Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Prev Biomarkers 25, 16–27, 2016.
   PubMed Web of Science ®Google Scholar
• Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, et al.: Trends in esophageal adenocarcinoma incidence and mortality. Cancer 119, 1149–1158, 2013.
   PubMed Web of Science ®Google Scholar
• Gholipour M, Islami F, Roshandel G, Khoshnia M, Badakhshan A, et al.: Esophageal cancer in golestan province, Iran: A review of genetic susceptibility and environmental risk factors. Middle East J Dig Dis 8, 249–266, 2016.
   PubMedGoogle Scholar
• Rasool MT, Lone MM, Wani ML, Afroz F, Zaffar S, et al.: Cancer in Kashmir, India: Burden and pattern of disease. J Cancer Res Ther 8(2), 243–246, 2012.
   PubMed Web of Science ®Google Scholar
• Dar NA, Bhat GA, Shah IA, Iqbal B, Makhdoomi MA, et al.: Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br J Cancer 107, 1618–1623, 2012.
   PubMed Web of Science ®Google Scholar
• Rafiq R, Shah IA, Bhat GA, Lone MM, Islami F, et al.: Secondhand smoking and the risk of esophageal squamous cell carcinoma in a high incidence region, Kashmir, India: A case-control–observational study. Medicine 95(1), e2340, 2016.
   PubMed Web of Science ®Google Scholar
• Mir MM, and Dar NA: Esophageal cancer in kashmir (India): An enigma for researchers. Int J Health Sci (Qassim) 3, 71–85, 2009.
   PubMedGoogle Scholar
• Siddiqi MA, Tricker AR, Kumar R, Fazili Z, and Preussmann R: Dietary sources of N-nitrosamines in a high-risk area for oesophageal cancer–Kashmir, India. IARC Sci Publ 210–213, 1991.
   PubMedGoogle Scholar
• Siddiqi M, Tricker AR, and Preussmann R: The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer Lett 39, 37–43, 1988.
   PubMed Web of Science ®Google Scholar
• Dar N, Islami F, Bhat G, Shah I, Makhdoomi M, et al.: Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir. Br J Cancer 109, 1367–1372, 2013.
   PubMed Web of Science ®Google Scholar
• Dar NA, Bhat GA, Shah IA, Iqbal B, Rafiq R, et al.: Salt tea consumption and esophageal cancer: A possible role of alkaline beverages in esophageal carcinogenesis. Int J Cancer 136(6), E704–710, 2015.
   PubMed Web of Science ®Google Scholar
• Dar NA, Shah IA, Bhat GA, Makhdoomi MA, Iqbal B, et al.: Socioeconomic status and esophageal squamous cell carcinoma risk in Kashmir, India. Cancer Sci 104, 1231–1236, 2013.
   PubMed Web of Science ®Google Scholar
• Bhat G, Shah I, Rafiq R, Nabi S, Iqbal B, et al.: Family history of cancer and the risk of squamous cell carcinoma of oesophagus: A case–control study in Kashmir, India. Br J Cancer 113, 524–532, 2015.
   PubMed Web of Science ®Google Scholar
• Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, et al.: CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir. Tumor Biol 35, 5323–5330, 2014.
   PubMed Web of Science ®Google Scholar
• Makhdoomi MA, Shah IA, Bhat GA, Amin S, Lone MM, et al.: Association between GSTM1 and GSTT1 polymorphisms and esophageal squamous cell carcinoma: results from a case-control study in Kashmir, India. Tumor Biol 36, 2613–2619, 2015.
   PubMedGoogle Scholar
• Shah I, Mehta P, Lone M, and Dar N: Leu432Val Polymorphism of CYP1B1 is Not associated with squamous cell carcinoma of esophagus—A case-control study from Kashmir, India. Asian Pac J Cancer Prev 16, 5337–5341, 2015.
   PubMedGoogle Scholar
• Rafiq R, Bhat GA, Lone MM, Masood A, and Dar NA: Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors. Tumor Biol 37, 10193–10207, 2016.
   PubMedGoogle Scholar
• Shah I, Bhat G, Mehta P, Lone M, and Dar N: Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: Outcome of a case-control study from Kashmir, India. Dis Esophagus 29, 937–943, 2016.
   PubMed Web of Science ®Google Scholar
• Bhat GA, Bhat AB, Lone MM, and Dar NA: Association of genetic variants of CYP2C19 and CYP2D6 with esophageal squamous cell carcinoma risk in Northern India, Kashmir. Nutr Cancer 69, 585–592, 2017.
   PubMed Web of Science ®Google Scholar
• Malik MA, Upadhyay R, Mittal RD, Zargar SA, and Mittal B: Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer 62, 734–742, 2010.
   PubMed Web of Science ®Google Scholar
• Malik MA, Sharma KL, Zargar SA, and Mittal B: Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley. Saudi J Gastroenterol 17(5), 301–306, 2011.
   PubMed Web of Science ®Google Scholar
• Malik MA, Umar M, Gupta U, Zargar SA, and Mittal B: Phospholipase C epsilon 1 (PLCE1 rs2274223A>G, rs3765524C>T and rs7922612C>T) polymorphisms and esophageal cancer risk in the Kashmir Valley. Asian Pac J Cancer Prev 15, 4319–4323, 2014.
   PubMedGoogle Scholar
• Rasool S, Ganai BA, Kadla SA, Ahanger AG, Qazi F, et al.: The ECRG1 290Arg/Gln polymorphism is related to risk of esophageal squamous cell carcinoma in Kashmir. Asian Pac J Cancer Prev 12, 265–269, 2011.
   PubMedGoogle Scholar
• Hussain S, Thakur N, Salam I, Singh N, Mir MM, et al.: Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley—a high risk area. Mol Carcinog 50, 487–498, 2011.
   PubMed Web of Science ®Google Scholar
• Xue H, Lu Y, Xue Z, Lin B, Chen J, et al.: The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: A systematic review and meta-analysis. Tumor Biol 35, 4741–4756, 2014.
   PubMedGoogle Scholar
• Faber MS, Jetter A, and Fuhr U: Assessment of CYP1A2 activity in clinical practice: Why, how, and when? Basic Clin Pharmacol Toxicol 97, 125–134, 2005.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Antona C, and Ingelman-Sundberg M: Cytochrome P450 pharmacogenetics and cancer. Oncogene 25, 1679–1691, 2006.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang Z, Han S, Lu Y, Feng F, et al.: CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: A meta-analysis from 19 case-control studies. BMC Cancer 12, 528, 2012.
   PubMed Web of Science ®Google Scholar
• Sun W-X, Chen Y-H, Liu Z-Z, Xie J-J, Wang W, et al.: Association between the CYP1A2 polymorphisms and risk of cancer: A meta-analysis. Mol Genet Genomics 290, 709–725, 2015.
   PubMed Web of Science ®Google Scholar
• Tian Z, Li Y-L, Zhao L, and Zhang C-L: Role of CYP1A2* 1F polymorphism in cancer risk: Evidence from a meta-analysis of 46 case–control studies. Gene 524, 168–174, 2013.
   PubMed Web of Science ®Google Scholar
• Vukovic V, Ianuale C, Leoncini E, Pastorino R, Gualano MR, et al.: Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses. BMC Cancer 16, 83, 2016.
   PubMed Web of Science ®Google Scholar
• Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, et al.: Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry 20, 647–656, 2015.
   PubMed Web of Science ®Google Scholar
• Kumar R, Mende P, Wacker C-D, Spiegelhalder B, Preussmann R, et al.: Caffeine-derived N-nitroso compounds—I: Nitrosatable precursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India. Carcinogenesis 13, 2179–2182, 1992.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Rusell. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 2001.
   Google Scholar
• Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, et al.: Detection of three genetic polymorphisms in the 5′‐flanking region and intron 1 of human CYP1A2 in the Japanese population. Cancer Sci 90, 899–902, 1999.
   Google Scholar
• Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al.: Socio-economic status and oesophageal cancer: Results from a population-based case-control study in a high-risk area. Int J Epidemiol 38, 978–88, 2009.
   PubMed Web of Science ®Google Scholar
• Cornelis M, El-Sohemy A, and Campos H: Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J Med Genet 41, 758–762, 2004.
   PubMed Web of Science ®Google Scholar
• Miranda CL, Yang Y-H, Henderson MC, Stevens JF, Santana-Rios G, et al.: Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo [4, 5-f] quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metab Dispos 28, 1297–1302, 2000.
   PubMed Web of Science ®Google Scholar
• MacLeod S, Tang Y, Yokoi T, Kamataki T, Doublin S, et al.: The role of recently discovered genetic polymorphism in the regulation of the human CYP1A2 gene. Proc Am Assoc Cancer Res 39, 396, 1998.
   Google Scholar
• Sachse C, Brockmöller J, Bauer S, and Roots I: Functional significance of a C→ A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47, 445–449, 1999.
   PubMed Web of Science ®Google Scholar
• He X-F, Wei J, Liu Z-Z, Xie J-J, Wang W, et al.: Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: A meta-analysis. PLoS ONE 9(8): e100487, 2014.
   PubMed Web of Science ®Google Scholar
• Ghoshal U, Tripathi S, Kumar S, Mittal B, Chourasia D, et al.: Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer 17, 226–234, 2014.
   PubMed Web of Science ®Google Scholar
• Moonen H, Engels L, Kleinjans J, de Kok T: The CYP1A2-164A→ C polymorphism (CYP1A2* 1F) is associated with the risk for colorectal adenomas in humans. Cancer Lett 229, 25–31, 2005.
   PubMed Web of Science ®Google Scholar
• Goodman MT, Tung K-H, McDuffie K, Wilkens LR, and Donlon TA: Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 46, 23–29, 2003.
   PubMed Web of Science ®Google Scholar
• Tao L, Xiang YB, Chan KK, Wang R, Gao YT, et al.: Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study. Int J Cancer 130, 1174–1183, 2012.
   PubMed Web of Science ®Google Scholar
• Long JR, Egan KM, Dunning L, Shu XO, Cai Q, et al.: Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics 16, 237–243, 2006.
   PubMed Web of Science ®Google Scholar
• Singh AP, Pant MC, Ruwali M, Shah PP, Prasad R, et al.: Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men. Cancer Biomarkers: Sect A Dis Markers 8, 351–359, 2009.
   Web of Science ®Google Scholar
• Sim SC: CYP1A21* F contains the− 163C>A substitution and is highly inducible. Pharmacogenet Genomics 23, 104–105, 2013.
   PubMed Web of Science ®Google Scholar
• Anderson GD, and Chan L-N: Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products. Clin Pharmacokinet 55, 1353–1368, 2016.
   PubMed Web of Science ®Google Scholar
• Musgrave IF, Farrington RL, Hoban C, and Byard RW: Caffeine toxicity in forensic practice: Possible effects and under-appreciated sources. Forensic Sci Med Pathol 12, 299–303, 2016.
   PubMed Web of Science ®Google Scholar
• Erdinger L, Schmezer P, Razdan R, Kumar R, Spiegelhalder B, et al.: Caffeine-derived N-nitroso compounds. III: Mutagenicity in S. typhimurium and in vitro induction of DNA single-strand breaks in rat hepatocytes by mononitrosocaffeidine and dinitrosocaffeidine. Mutation Res/Environ Mutagen Relat Subj (Lond) 292, 41–49, 1993.
   PubMed Web of Science ®Google Scholar
• Ivankovic S, Seibel J, Komitowski D, Spiegelhalder B, Preussmann R, et al.: Caffeine-derived N-nitroso compounds. V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis 19, 933–937, 1998.
   PubMed Web of Science ®Google Scholar
• Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93, 17–48, 1995.
   PubMed Web of Science ®Google Scholar
• Jakszyn P, and González CA: Nitrosamine and related food intake and gastric and oesophageal cancer risk: A systematic review of the epidemiological evidence. World J Gastroenterol 12, 4296–4303, 2006.
   PubMed Web of Science ®Google Scholar
• Keszei AP, Goldbohm RA, Schouten LJ, Jakszyn P, and van den Brandt PA: Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am J Clin Nutr 97(1), 135–146, 2012.
   PubMed Web of Science ®Google Scholar